Liraglutide ameliorates myocardial damage in experimental diabetic rats by inhibiting pyroptosis via Sirt1/AMPK signaling

OBJECTIVE(S): Liraglutide, a well-established drug for treating diabetes mellitus (DM), has recently gained attention for its cardiovascular benefits in diabetes via multiple cellular activities; however, whether liraglutide improves myocardial damage by inhibiting pyroptosis and the mechanisms of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zhe, Wang, Xing, Yang, Linlin, Yang, Linquan, Ma, Huijuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mashhad University of Medical Sciences 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769506/
https://www.ncbi.nlm.nih.gov/pubmed/35096293
http://dx.doi.org/10.22038/IJBMS.2021.56771.12677

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769506/
https://www.ncbi.nlm.nih.gov/pubmed/35096293
http://dx.doi.org/10.22038/IJBMS.2021.56771.12677

Ejemplares similares